Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06940011
PHASE2

Endocalyx in Treatment Resistent Hypertension

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

View on ClinicalTrials.gov

Summary

The goal of this randomized, double-blind, placebo-controlled study is to assess whether the food supplement Endocalyx lowers blood pressure in patients with treatment resistant hypertension.

Official title: Glycocalyx Restoration in Treatment Resistant Hypertension: a Proof of Concept, Randomized, Double-blind, Placebo-controlled Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2025-01-21

Completion Date

2028-01-01

Last Updated

2025-04-23

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Endocalyx Pro

4 capsules once daily OR 2 capsules twice daily

OTHER

Placebo

4 capsules once daily OR 2 capsules twice daily

Locations (1)

Amsterdam UMC

Amsterdam, North Holland, Netherlands